Holland-Frei Cancer Medicine, 8th Edition

By

• Waun Ki Hong, MD, DMSc (Hon), Head and Professor, Division of Cancer Medicine, American Cancer Society Professor, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
• Robert C. Bast, Jr, MD, Vice President for Translational Research, Harry Carrothers Wiess Distinguished University Chair for Cancer Research, Professor of Medicine, Department of Experimental Therapeutics MD Anderson Cancer Center, The University of Texas, Houston, Texas
• William N. Hait, MD, PhD, Senior Vice President and Worldwide Head, Ortho Biotech Oncology Research & Development, A Unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.D.
• Donald W. Kufe, MD, Professor of Medicine, Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
• Raphael E. Pollock, MD, PhD, Professor and Chairman, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center
• Ralph R. Weichselbaum, MD, Professor and Chairman, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois
• James F. Holland, MD, Professor, Department of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, New York
• Emil Frei III, MD, Physician in Chief, Emeritus, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts